BlackRock’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.4M | Buy |
571,673
+73,692
| +15% | +$1.33M | ﹤0.01% | 3344 |
|
|
2025
Q1 | $10.2M | Buy |
497,981
+56,463
| +13% | +$1.16M | ﹤0.01% | 3269 |
|
|
2024
Q4 | $11.3M | Buy |
441,518
+374,845
| +562% | +$9.63M | ﹤0.01% | 3320 |
|
|
2024
Q3 | $1.11M | Buy |
66,673
+25,028
| +60% | +$415K | ﹤0.01% | 4102 |
|
|
2024
Q2 | $800K | Buy |
41,645
+30,425
| +271% | +$584K | ﹤0.01% | 4178 |
|
|
2024
Q1 | $265K | Sell |
11,220
-11,721
| -51% | -$277K | ﹤0.01% | 4467 |
|
|
2023
Q4 | $256K | Hold |
22,941
| – | – | ﹤0.01% | 4501 |
|
|
2023
Q3 | $212K | Buy |
+22,941
| New | +$212K | ﹤0.01% | 4594 |
|